Aarti Pharmalabs Ltd.

Aarti Pharmalab has informed that the meeting of the Board of Directors of Aarti Pharmalabs is scheduled to be held on Saturday, May 10, 2025, to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2025 and recommendation of dividend, if any, for the financial year ended March 31, 2025.

The above information is a part of company’s filings submitted to BSE.